Donidalorsen (ISIS 721744 / IONIS-PKK-LRx)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donidalorsen (ISIS 721744 / IONIS-PKK-LRx), covering 2025-03-06 to 2025-03-06. Get the full timeline:
Most recent: Clinical Trial Update: OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE) [Phase 3]